GlassScriptPhysician profile
Kyle S Nay
NPI 1275966004
$4,975.83
in general payments reported to CMS, 2019-2025
25 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,131 · 2020: $91.89 · 2021: $2,558 · 2022: $83.34 · 2023: $60.17 · 2024: $558 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $2,453.14 | 2021 | |
| Gemini Mountain Medical, LLC | $996.00 | 2019 | |
| Mimedx Group, INC. | $290.33 | 2024-2025 | |
| Kerecis Limited | $171.76 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Sawtooth Surgical Solutions INC | $128.11 | 2024-2025 | |
| Treace Medical Concepts, INC. | $118.99 | 2019 | |
| Arthrex, INC. | $114.43 | 2024 | |
| Stryker Corporation | $92.94 | 2021-2022 | |
| Integra Lifesciences Corporation | $87.83 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $81.80 | 2022-2023 | Puraply |
| Averitas Pharma INC. | $78.41 | 2024 | Qutenza |
| Hydrocision, INC. | $77.17 | 2024 | Tenjet |
| Smith+Nephew, INC. | $62.79 | 2020-2024 | Renasys Go V2 Home |
| Exact Sciences Corporation | $44.03 | 2023-2024 | Cologuard Collection Kit |
| Medical Device Business Services, INC. | $29.03 | 2024 | Fibulink |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.54 | 2024 | |
| Acera Surgical, INC. | $19.01 | 2021 | |
| Merck Sharp & Dohme LLC | $16.38 | 2019 | |
| Bioventus LLC | $15.12 | 2020 | |
| Innovation Technologies INC | $14.79 | 2025 | Irrisept |
| Acumed LLC | $13.90 | 2021 | |
| Paratek Pharmaceuticals, INC. | $12.70 | 2022 | |
| Depuy Synthes Sales INC. | $12.04 | 2020 | |
| Biowound Solutions, INC. | $11.50 | 2025 | Bio-Connekt |
| Horizon Therapeutics Plc | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Nay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.